These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-001647-30 An open-label study to evaluate the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL) not-yet-due
Listed as ongoing, but also has a completion date 2004-001861-17 EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL). 2008-06-27 bad-data
Ongoing 2005-004599-19 INTERFANT 06 not-yet-due
Completed, but no date 2006-001549-32 Prospectic, multicentric, randomized, controlled trial for the evaluation of efficacy of Caspofungin vs Amfotericina B liposomiale for the empirical treatment of the FUO in children neutropenic for an... bad-data
Completed, but no date Terminated 2006-005673-21 PROTOCOL OF DIAGNOSIS AND THERAPY FOR RETINOBLASTOMA - AIEOP RB 05 bad-data
Ongoing 2008-002311-40 ICC APL STUDY 01 TREATMENT STUDY FOR CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA not-yet-due
Ongoing 2010-019224-31 INTERGROUP TRIAL FOR CHILDREN OR ADOLESCENTS WITH B-CELL NHL OR B-AL: EVALUATION OF RITUXIMAB EFFICACY AND SAFETY IN HIGH RISK PATIENTS not-yet-due
Other 2010-021396-81 European Low and Intermediate Risk Neuroblastoma not-yet-due
Other 2011-000990-29 Multinational european trial for children with the opsoclonus myoclonus syndrome/dancing eye syndrome. not-yet-due
Not reported Terminated 2011-006109-85 DIAGNOSTIC AND THERAPEUTIC STUDY FOR NEWLY DIAGNOSED RETINOBLASTOMA PATIENTS RTB AIEOP 012 2018-01-03 due-trials
Ongoing 2012-003092-19 Reinduction protocol for patients with high-risk neuroblastoma in first relapse not-yet-due
Ongoing 2014-000652-28 Study Protocol LAM 2013/01 not-yet-due
Other 2016-001935-12 AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia not-yet-due